Prestige Consumer Healthcare (PBH) Exchange Rate Effect (2011 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly Exchange Rate Effect of $272000.0 for Q4 2025, up 113.1% year-over-year from $127638.3 in Q4 2024, and up 6900.0% quarter-over-quarter from -$4000.0 in Q3 2025.
Prestige Consumer Healthcare (PBH) Exchange Rate Effect (2011 - 2025) Analysis & Trends
Prestige Consumer Healthcare's Exchange Rate Effect history runs 15 years deep, the most recent figure standing at $272000.0 for Q4 2025.
- In Q4 2025, Exchange Rate Effect rose 113.1% year-over-year to $272000.0; the TTM figure through Dec 2025 stood at $1.2 million (up 193.5% YoY), while the FY2025 annual figure was -$573000.0, down 418.33% from the prior year.
- Exchange Rate Effect for Q4 2025 stood at $272000.0, up from -$4000.0 in the prior quarter.
- The five-year high for Exchange Rate Effect was $1.4 million in Q4 2023, with the low at -$2.1 million in Q4 2024.
- The 5-year median for Exchange Rate Effect is -$72000.0 (2023), against an average of -$76200.0.
- Peak annual rise in Exchange Rate Effect reached 573.57% in 2024, while the deepest fall reached 20066.67% in 2024.
- Prestige Consumer Healthcare's Exchange Rate Effect stood at -$230000.0 in 2021, then jumped by 446.96% to $798000.0 in 2022, then surged by 77.32% to $1.4 million in 2023, then tumbled by 246.71% to -$2.1 million in 2024, then soared by 113.1% to $272000.0 in 2025.
- Business Quant data shows PBH's Exchange Rate Effect at $272000.0 in Q4 2025, -$4000.0 in Q3 2025, and $825000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -5.00 Mn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -7.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 39.87 Mn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | -3.30 Mn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 9.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.46 Bn | 2.39 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 272,000.00 |
| Dec 31, 2025 | 272,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Sep 30, 2025 | -4,000.00 |
| Jun 30, 2025 | 825,000.00 |
| Jun 30, 2025 | 825,000.00 |
| Mar 31, 2025 | 129,000.00 |
| Mar 31, 2025 | 129,000.00 |
| Dec 31, 2024 | -2.08 Mn |
| Dec 31, 2024 | -2.08 Mn |
| Sep 30, 2024 | 711,000.00 |
| Sep 30, 2024 | 711,000.00 |
| Jun 30, 2024 | 663,000.00 |
| Jun 30, 2024 | 663,000.00 |
| Mar 31, 2024 | -605,000.00 |
| Mar 31, 2024 | -605,000.00 |
| Dec 31, 2023 | 1.42 Mn |
| Dec 31, 2023 | 1.42 Mn |
| Sep 30, 2023 | -490,000.00 |
| Sep 30, 2023 | -490,000.00 |